pharmacy benefit managers Pharmacists Pushing for DIR Relief March 15, 2017 By Christine Blank Community pharmacists fight against financial pressure for their survival. Health execs must brace for autoimmune drug changes October 05, 2016 By Tracey Walker A comprehensive understanding of this rapidly increasing drug class is essential to integrate pharmacy and medical claim information. Walgreens-Prime alliance: A new breed pharmacy strategy? September 02, 2016 By Tracey Walker This model, touted as “next-generation,” combines retail and specialty and mail services and PBM along with immediate care clinics. Top 4 pharmacy trends healthcare executives should watch August 28, 2016 By Karen Appold Managed Healthcare Executive conducted its first-ever managed care pharmacy survey during the second quarter of 2016 in partnership with Access Market Intelligence. Here’s a look at some of the key findings, with experts weighing in on the results. Drug spending rising at slower pace March 21, 2016 By Tracey Walker PBM Express Scripts shares findings from its new Drug Trend Report. CMS unveils enhanced MTM program March 06, 2016 By Mari Edlin Model set to improve compliance, reduce costs, but reimbursement challenges remain. Specialty pharmacies: The payer’s dilemma January 07, 2016 By Mari Edlin Payers weigh the benefits of using their own resources to develop a specialty pharmacy or contracting outside for services. Express Scripts to offer low-cost option to Daraprim December 02, 2015 By Tracey Walker Express Scripts is partnering with Imprimis Pharmaceuticals to provide access to a low-cost alternative to Daraprim (pyrimethamine). Here's why. AMCP president identifies top managed care pharmacy challenges October 14, 2015 By Aubrey Westgate Raulo Frear, AMCP president, discusses the upcoming AMCP conference and some of the top challenges and opportunities facing the managed care pharmacy industry. Read more. When cheap drugs suddenly become expensive October 01, 2015 By Tracey Walker The reasons for recent jumps in generic drug prices are varied, but some common themes have emerged in a new study by National Center for Policy Analysis Senior Fellow Devon Herrick.